Qingzhen Yu

800 total citations
24 papers, 527 citations indexed

About

Qingzhen Yu is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Qingzhen Yu has authored 24 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Qingzhen Yu's work include Catalytic C–H Functionalization Methods (8 papers), Synthesis and Catalytic Reactions (5 papers) and Catalytic Cross-Coupling Reactions (4 papers). Qingzhen Yu is often cited by papers focused on Catalytic C–H Functionalization Methods (8 papers), Synthesis and Catalytic Reactions (5 papers) and Catalytic Cross-Coupling Reactions (4 papers). Qingzhen Yu collaborates with scholars based in China, United States and Japan. Qingzhen Yu's co-authors include Jianhui Huang, Le’an Hu, Shasha Zheng, Yue Wang, Kang Zhao, Nana Zhang, Jing Xu, Yi Zhu, Xiaoxiao Yu and Yuye Chen and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Hepatology.

In The Last Decade

Qingzhen Yu

22 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingzhen Yu China 11 418 95 59 42 30 24 527
Yeon Joo Kim South Korea 13 318 0.8× 54 0.6× 80 1.4× 41 1.0× 30 1.0× 21 473
Johan Wannberg Sweden 13 514 1.2× 104 1.1× 229 3.9× 42 1.0× 23 0.8× 26 683
Attila Takács Hungary 16 460 1.1× 68 0.7× 198 3.4× 24 0.6× 17 0.6× 44 687
Patrik Nordeman Sweden 14 367 0.9× 98 1.0× 145 2.5× 149 3.5× 33 1.1× 30 599
Tony Gibson United States 13 315 0.8× 51 0.5× 176 3.0× 37 0.9× 25 0.8× 21 466
Seigo Ishibuchi Japan 10 166 0.4× 25 0.3× 175 3.0× 21 0.5× 30 1.0× 14 370
Laurent Sanière France 7 258 0.6× 42 0.4× 78 1.3× 6 0.1× 26 0.9× 11 373
Dayong Zhang China 11 186 0.4× 34 0.4× 51 0.9× 17 0.4× 35 1.2× 18 327
Hwan Jung Lim South Korea 14 471 1.1× 122 1.3× 126 2.1× 25 0.6× 16 0.5× 33 628
Lena Ripa Sweden 12 210 0.5× 47 0.5× 127 2.2× 9 0.2× 27 0.9× 16 359

Countries citing papers authored by Qingzhen Yu

Since Specialization
Citations

This map shows the geographic impact of Qingzhen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingzhen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingzhen Yu more than expected).

Fields of papers citing papers by Qingzhen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingzhen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingzhen Yu. The network helps show where Qingzhen Yu may publish in the future.

Co-authorship network of co-authors of Qingzhen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingzhen Yu. A scholar is included among the top collaborators of Qingzhen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingzhen Yu. Qingzhen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiahui, Yinlong Li, Qingzhen Yu, et al.. (2024). Preclinical Evaluation of Azabenzimidazole‐Based PET Radioligands for γ‐8 Dependent Transmembrane AMPA Receptor Regulatory Protein Imaging. ChemBioChem. 25(6). e202300813–e202300813.
2.
Wang, Qiuling, et al.. (2022). Efficacy and Safety of Annual Infusion of Zoledronic Acid and Weekly Oral Alendronate in the Treatment of Primary Osteoporosis: A Meta‐Analysis. The Journal of Clinical Pharmacology. 63(4). 455–465. 6 indexed citations
3.
Yu, Qingzhen, et al.. (2022). Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing. Frontiers in Oncology. 12. 791332–791332. 4 indexed citations
4.
Wang, Kefeng, et al.. (2022). Copper-catalyzed radical trans-selective hydroboration of ynamides with N-heterocyclic carbene boranes. iScience. 25(9). 104977–104977. 6 indexed citations
5.
Shao, Tuo, Zhen Chen, Jian Rong, et al.. (2021). [18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models. Acta Pharmaceutica Sinica B. 12(1). 308–315. 17 indexed citations
6.
Deng, Xiaoyun, Yiding Zhang, Zhen Chen, et al.. (2020). Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[11C]methoxyphenethyl)pyridazin-3(2H)-one, a 11C-labeled -amino acid oxidase (DAAO) inhibitor for PET imaging. Bioorganic & Medicinal Chemistry Letters. 30(16). 127326–127326. 4 indexed citations
7.
Chen, Zhen, Jiahui Chen, Natalia Mast, et al.. (2020). Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using ‘in-loop’ [11C]CO2 fixation method. Bioorganic & Medicinal Chemistry Letters. 30(9). 127068–127068. 10 indexed citations
8.
Shao, Tuo, Zhen Chen, Vasily Belov, et al.. (2020). [18F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis. Journal of Hepatology. 73(1). 161–169. 29 indexed citations
10.
Yu, Qingzhen, Katsushi Kumata, Hua Li, et al.. (2019). Synthesis and evaluation of 6-(11C-methyl(4-(pyridin-2-yl)thiazol-2-yl)amino)benzo[d]thiazol-2(3H)-one for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein by PET. Bioorganic & Medicinal Chemistry Letters. 30(4). 126879–126879. 1 indexed citations
11.
Chen, Zhen, Tuo Shao, Wei Gao, et al.. (2019). Synthesis and Preliminary Evaluation of [11C]GNE‐1023 as a Potent PET Probe for Imaging Leucine‐Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease. ChemMedChem. 14(17). 1580–1585. 13 indexed citations
12.
Zhu, Ranran, et al.. (2018). Selectfluor-mediated mono-C–H activation: The syntheses of mono-ortho-substituted anilides. Tetrahedron. 74(28). 3879–3887. 12 indexed citations
13.
Hu, Le’an, et al.. (2017). Selective mono-alkylation of N-methoxybenzamides. Chemical Communications. 53(30). 4258–4261. 18 indexed citations
14.
Yu, Qingzhen, Le’an Hu, Yue Wang, Shasha Zheng, & Jianhui Huang. (2015). Directed meta‐Selective Bromination of Arenes with Ruthenium Catalysts. Angewandte Chemie International Edition. 54(50). 15284–15288. 170 indexed citations
15.
Yu, Qingzhen, Le’an Hu, Yue Wang, Shasha Zheng, & Jianhui Huang. (2015). Directed meta‐Selective Bromination of Arenes with Ruthenium Catalysts. Angewandte Chemie. 127(50). 15499–15503. 42 indexed citations
16.
Liu, Weidong, et al.. (2015). Modular synthesis of dihydro-isoquinolines: palladium-catalyzed sequential C(sp2)–H and C(sp3)–H bond activation. Chemical Science. 6(10). 5768–5772. 28 indexed citations
17.
Yu, Qingzhen, Nana Zhang, Jianhui Huang, et al.. (2013). Efficient Synthesis of Hydroxyl Isoindolones by a Pd‐Mediated CH Activation/Annulation Reaction. Chemistry - A European Journal. 19(34). 11184–11188. 68 indexed citations
18.
Zhang, Nana, et al.. (2013). Synthesis of biaryl imino/keto carboxylic acids via aryl amide directed C–H activation reaction. Chemical Communications. 49(82). 9464–9464. 26 indexed citations
20.
Du, Yunfei, Kang Zhao, Qingzhen Yu, et al.. (2012). Copper(II)-Mediated Cascade Oxidative C-C Coupling and Aromatization: Synthesis of 3-Hydroxyphenanthridinone Derivatives. Synthesis. 44(15). 2374–2384. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026